Parameter | Number (%) patients | |
---|---|---|
Aged 41–50 years (n=301) | Aged >50 years (n=135) | |
EDSS score: | ||
improvement (≤–1) | 33 (11.0%) | 12 (8.9%) |
stable (no change) | 219 (72.8%) | 90 (66.7%) |
progression (≥+1) | 49 (16.3%) | 33 (24.4%) |
Relapse free throughout the study | 272 (90.4%) | 127 (94.1%) |
Disease-progression freea | 252 (83.7%) | 102 (75.6%) |
Relapse free and disease-progression free | 228 (75.7%) | 96 (71.1%) |